Advances and challenges in gene therapies (part 2)


HOME PAGE COMMITTEE MITONICE COMMITTEE MYOLOGY COMMITTEE PROGRAMS TIMETABLE MYOLOGY MITONICE ABSTRACTS REGISTRATION TO REGISTER GROUP SPACE PERSONAL SPACE USEFUL INFORMATION VENUE AND ACCESS ACCOMMODATION CONTACT US OUR SPONSORS MYOLOGY CONGRESS MitoNice CONGRESS ABSTRACT BOOKS ABSTRACT BOOK MITONICE ABSTRACT BOOK MYOLOGY
Advances and challenges in gene therapies (part 2) Wednesday, September 14, 2022 PLENARY • 14-PM-PLENARY • 2:30 PM > 4:00 PM • Advances and challenges in gene therapies (part 2) • Apollon Auditorium 2:30 PM • S12L1 • X-linked myotubular myopathy and liver dysfunction > A. Ana BUJ-BELLO (Evry, France) 3:00 PM • S12L2 • Modelling and editing Duchenne Muscular Dystrophy > W-H. Wolfram-Hubertus ZIMMERMANN (Goettingen, Germany) 3:30 PM • S12L3 • Application of CRISPR/Cas9 strategy for gene therapy of Myotonic Dystrophy type 1 > G. Germana FALCONE (Monterotondo, Italy)